BP
Balanced Pharma Inc
SEC filingPharmaceuticals · Cornelius, NC
Amount raised$3.2Msold at filing
Total offering$3.2M
Investors in the raise1count reported to the SEC
FiledSep 23, 2025first sale Nov 27, 2024
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
MARK SCOTT SEBREEDirector
JOHN SCOTT KEADLEExecutive Officer, Director
JOHN SCOTT SELIGDirector
ATIF SCOTT ZIADirector
RICHARD SCOTT NONELLEDirector
Executive officers, directors and promoters as listed on the Form D.